Cargando…

NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma

BACKGROUND: Glioma is a fatal primary malignant tumor. We aimed to explore the effect of nuclear receptor subfamily 5 group A member 2 (NR5A2) on glioma. METHODS: NR5A2 expression in glioma tissues and cells was detected using qRT-PCR and immunohistochemistry (IHC)/Western blot. SPSS 22.0 was perfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Quanxi, Deng, Lei, Li, Jialiang, Miao, Pengfei, Liu, Wenxiang, Huang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567570/ https://www.ncbi.nlm.nih.gov/pubmed/33116604 http://dx.doi.org/10.2147/OTT.S243833

Ejemplares similares

LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
por: Baisiwala, Shivani, et al.
Publicado: (2020)

Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma
por: Wang, Chao, et al.
Publicado: (2018)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis
por: Luo, Kui, et al.
Publicado: (2022)

NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling
por: Gu, Guangyan, et al.
Publicado: (2019)

Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
por: Meng, Xiangqi, et al.
Publicado: (2020)

Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy
por: Ming, Jianguang, et al.
Publicado: (2017)

Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Ding, Yiming, et al.
Publicado: (2021)

Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway
por: WANG, YAWEI, et al.
Publicado: (2016)

CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022)

RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 Pathway
por: Lin, Yan, et al.
Publicado: (2021)

Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Rao, Jyotsna U., et al.
Publicado: (2017)

MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway
por: Tan, Zhigang, et al.
Publicado: (2018)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Neuritin Inhibits Notch Signaling through Interacted with Neuralized to Promote the Neurite Growth
por: Zhang, Pan, et al.
Publicado: (2017)

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
por: Cao, Yingxiao, et al.
Publicado: (2020)

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
por: Yu, Zhiyun, et al.
Publicado: (2015)

Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma
por: Ding, Chenyu, et al.
Publicado: (2021)

Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway
por: Zeng, Fei, et al.
Publicado: (2018)

Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide
por: Gerstmeier, Julia, et al.
Publicado: (2021)

GASC1 promotes glioma progression by enhancing NOTCH1 signaling
por: Xiao, Zhengzheng, et al.
Publicado: (2021)

Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
por: Zając, Adrian, et al.
Publicado: (2021)

MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
por: Wang, Hongqin, et al.
Publicado: (2019)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Integrin Beta 1 Promotes Glioma Cell Proliferation by Negatively Regulating the Notch Pathway
por: Min, Weijie, et al.
Publicado: (2020)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Glioma and temozolomide induced alterations in gut microbiome
por: Patrizz, Anthony, et al.
Publicado: (2020)

Temozolomide Chronotherapy in Glioma: A Systematic Review
por: Jia, Jason L., et al.
Publicado: (2023)

Notch intracellular domain regulates glioblastoma proliferation through the Notch1 signaling pathway
por: Wang, Yixuan, et al.
Publicado: (2021)

UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway
por: Wang, Yang, et al.
Publicado: (2023)

MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
por: Zhou, Xu, et al.
Publicado: (2017)

Mechanism of BMP9 promotes growth of osteosarcoma mediated by the Notch signaling pathway
por: LIU, PENG, et al.
Publicado: (2016)

The Different Role of Notch1 and Notch2 in Astrocytic Gliomas
por: Xu, Peng, et al.
Publicado: (2013)

Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

KDELR2 knockdown synergizes with temozolomide to induce glioma cell apoptosis through the CHOP and JNK/p38 pathways
por: Zhang, Guofeng, et al.
Publicado: (2021)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020)

NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway
por: Xu, Haiyang, et al.
Publicado: (2018)

Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis
por: Deng, Yanyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k1vvnb6abqoh9ge57s27e6ems8